KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.91 $2.71 Thursday, 25th Apr 2024 CANF stock ended at $1.92. This is 1.03% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.62% from a day low at $1.92 to a day high of $1.97.
90 days $1.91 $2.71
52 weeks $1.71 $3.33

Historical Can-Fite BioPharma Ltd prices

Date Open High Low Close Volume
Jun 03, 2022 $0.94 $0.99 $0.92 $0.95 67 728
Jun 02, 2022 $0.96 $0.96 $0.91 $0.96 41 304
Jun 01, 2022 $0.92 $0.95 $0.90 $0.94 35 527
May 31, 2022 $0.88 $0.98 $0.88 $0.94 108 649
May 27, 2022 $0.84 $0.90 $0.84 $0.90 45 063
May 26, 2022 $0.84 $0.89 $0.83 $0.86 123 182
May 25, 2022 $0.87 $0.91 $0.84 $0.84 49 726
May 24, 2022 $0.87 $0.91 $0.85 $0.87 42 717
May 23, 2022 $0.91 $0.91 $0.87 $0.89 60 276
May 20, 2022 $0.88 $0.91 $0.88 $0.91 17 391
May 19, 2022 $0.87 $0.91 $0.87 $0.90 42 727
May 18, 2022 $0.90 $0.93 $0.86 $0.90 82 644
May 17, 2022 $0.86 $0.92 $0.86 $0.91 66 134
May 16, 2022 $0.90 $0.90 $0.86 $0.86 116 896
May 13, 2022 $0.83 $0.90 $0.82 $0.87 125 238
May 12, 2022 $0.82 $0.88 $0.782 $0.83 113 129
May 11, 2022 $0.85 $0.90 $0.780 $0.84 156 834
May 10, 2022 $0.89 $0.92 $0.83 $0.84 89 028
May 09, 2022 $0.91 $0.91 $0.81 $0.84 197 628
May 06, 2022 $0.97 $0.97 $0.91 $0.91 94 474
May 05, 2022 $0.98 $0.98 $0.94 $0.94 40 735
May 04, 2022 $0.98 $0.98 $0.93 $0.95 230 948
May 03, 2022 $0.97 $0.98 $0.93 $0.96 61 781
May 02, 2022 $1.04 $1.04 $0.92 $0.97 136 558
Apr 29, 2022 $0.95 $1.00 $0.93 $0.93 77 285
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT